Inission

Inission

Sälj aktien Köp aktien Handla aktien direkt på nordnet

« Tillbaka

Inission - We expect growth to accelerate further in Q4

27 januari 2026

  • Strong orders should continue to convert into sales growth (17%)
  • Enedo stabilising as comps ease and cost savings take effect
  • Earnings recovery: EPS from SEK 3.0 in '25e to SEK 5.2 in '27e

Q4 expectations

Supported by the strong R12m book-to-bill of 1.18x, we expect the sales growth seen in Q3 (14%) to accelerate further in Q4, forecasting 17% (8% from M&A). The majority of the growth will come from the Inission segment, but the comps in Enedo have now started to ease substantially, and we therefore expect its y-o-y comparison to start stabilising in Q4, especially given the segment's YTD book-to-bill of 1.3x. We estimate a group adj. EBITA margin of 6.4% (5.2%), after adjusting for SEK 3.5m (0.6pp) in restructuring costs in Enedo, which we expect to be the last charges taken.

Estimate changes

We cut '26e-'27e adj. EBITA by 2%, purely as a result of updated FX rates.

Outlook and valuation

With strong organic growth in the Inission segment, and a clear path to profitability in Enedo given the implemented cost-saving measures and strong book-to-bill in the segment (management expects a return to profitability in Q1), we forecast a significant earnings recovery in the coming two years, as adj. EPS looks set to go from SEK 3.0 in '25e to SEK 4.6/5.2 in '26e/'27e. The share is currently trading at 11x-9x '26e-'27e P/E, compared to its 10-year historical median of 13x-9x and peers at 15x-13x.

Senaste artiklar från alla bolag

Datum Titel Bolag Typ
2026-03-12 StrongPoint - Investor update StrongPoint Analys
2026-03-08 Medicover - From build-out to fill-up Medicover Analys
2026-03-02 Qben Infra - Portfolio reshaping continues Qben Infra Analys
2026-02-27 Xplora Technologies - Record quarter driven by Se... Xplora Tech.. Analys
2026-02-24 Isofol Medical - From first lessons to second exe... Isofol Medical Analys
2026-02-24 B3 Consulting Group - Cost adjustments should lif... B3 Consulti.. Analys
2026-02-23 Ework Group - Market conditions yet to improve Ework Group Analys
2026-02-23 Formpipe - Good margins, but ACV lags Formpipe Analys
2026-02-23 Energy Save - Back to growth, but softer H1'26 ex... Energy Save Analys
2026-02-23 Fastpartner - Outlook taking a hit Fastpartner Analys
2026-02-23 Cavotec - Industry shines in cautious environment Cavotec Analys
2026-02-20 Arctic Paper - Still challenging Arctic Paper Analys
2026-02-20 Inission - Set for substantial earnings growth Inission Analys
2026-02-20 BTS Group - Ahead of plan on growth recovery BTS Group Analys
2026-02-20 Energy Save - OEM sales up, softer start to '26 e... Energy Save Analys
2026-02-20 Formpipe - Weaker ACV, but higher dividends Formpipe Analys
2026-02-20 B3 Consulting Group - Margin beat on cost cuts B3 Consulti.. Analys
2026-02-20 BTS Group - North America behind Q4 miss BTS Group Analys
2026-02-20 Skolon - Q4'25 momentum to also pay off in H1'26 Skolon Analys
2026-02-20 Ogunsen - Easier comps await in '26e Ogunsen Analys